NDC 72626-2701

Sofosbuvir and Velpatasvir

Velpatasvir And Sofosbuvir

Sofosbuvir and Velpatasvir is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Asegua Therapeutics Llc. The primary component is Velpatasvir; Sofosbuvir.

Product ID72626-2701_3176f9af-1cbb-4c22-a518-75ef434e218b
NDC72626-2701
Product TypeHuman Prescription Drug
Proprietary NameSofosbuvir and Velpatasvir
Generic NameVelpatasvir And Sofosbuvir
Dosage FormTablet, Film Coated
Route of AdministrationORAL
Marketing Start Date2018-11-14
Marketing CategoryNDA AUTHORIZED GENERIC / NDA AUTHORIZED GENERIC
Application NumberNDA208341
Labeler NameAsegua Therapeutics LLC
Substance NameVELPATASVIR; SOFOSBUVIR
Active Ingredient Strength100 mg/1; mg/1
Pharm ClassesOrganic Anion Transporting Polypeptide 1B1 Inhibitors [MoA],Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA],Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA],Hepatitis C Virus NS5A Inhibitor [EPC],Breast Cancer Resistance Protein Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC],RNA Replicase Inhibitors [MoA],Nucleoside Analog [EXT]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 72626-2701-1

2 BLISTER PACK in 1 CARTON (72626-2701-1) > 14 TABLET, FILM COATED in 1 BLISTER PACK
Marketing Start Date2018-11-14
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 72626-2701-1 [72626270101]

Sofosbuvir and Velpatasvir TABLET, FILM COATED
Marketing CategoryNDA AUTHORIZED GENERIC
Application NumberNDA208341
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2018-11-14

Drug Details

Active Ingredients

IngredientStrength
VELPATASVIR100 mg/1

OpenFDA Data

SPL SET ID:d0c1a945-4440-4b5c-81aa-693ed3db597c
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1799212
  • Pharmacological Class

    • Organic Anion Transporting Polypeptide 1B1 Inhibitors [MoA]
    • Organic Anion Transporting Polypeptide 1B3 Inhibitors [MoA]
    • Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA]
    • Hepatitis C Virus NS5A Inhibitor [EPC]
    • Breast Cancer Resistance Protein Inhibitors [MoA]
    • P-Glycoprotein Inhibitors [MoA]
    • Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor [EPC]
    • RNA Replicase Inhibitors [MoA]
    • Nucleoside Analog [EXT]

    NDC Crossover Matching brand name "Sofosbuvir and Velpatasvir" or generic name "Velpatasvir And Sofosbuvir"

    NDCBrand NameGeneric Name
    72626-2701Sofosbuvir and VelpatasvirVelpatasvir and Sofosbuvir
    61958-2201EpclusaVelpatasvir and Sofosbuvir
    61958-2203EpclusaVelpatasvir and Sofosbuvir
    61958-2204EpclusaVelpatasvir and Sofosbuvir
    61958-2205EpclusaVelpatasvir and Sofosbuvir

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.